Rinat Yerushalmi

6PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 24, 2026
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.

|Aug 25, 2025
Role of Radiotherapy in Elderly Patients (≥65 Years) With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.

Eran Sharon, Igor Snast, Rinat Yerushalmi

|Apr 03, 2024
BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization.

Rinat Yerushalmi, Adi Pomerantz, Ron Lewin

|Apr 08, 2022
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis.

Adi Pomerantz, Daliah Tsoref, Ahuva Grubstein

|Jun 09, 2021
A novel role for an old target: CD45 for breast cancer immunotherapy.

Annat Raiter, Oran Zlotnik, Julia Lipovetsky

|Nov 28, 2019
Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer.

Yosef Landman, Salomon Marcello Stemmer, Aaron Sulkes

Pageof 1

Frequent Collaborators

1 joint publications

Yosef Landman

1 joint publications

Annat Raiter

1 joint publications

Eran Sharon

1 joint publications

Igor Snast